Table II.
All | AFO | SIS-FES | |
---|---|---|---|
n | 27 | 13 | 14 |
Age (years) | 46±14 | 43±16 | 49±12 |
Sex | |||
Men | 22 | 10 | 12 |
Women | 5 | 3 | 2 |
Causes | |||
Haemorrhagic stroke | 10 | 3 | 7 |
Ischaemic stroke | 6 | 3 | 3 |
Traumatic brain injury | 6 | 4 | 2 |
Non-evolutive brain tumour | 4 | 3 | 1 |
Cerebral palsy | 1 | 0 | 1 |
Paretic side | |||
Left | 17 | 9 | 8 |
Right | 10 | 4 | 6 |
Time since onset (years) | 9±11 | 7±7 | 12±15 |
Function and pain | |||
MWFC (category (%)) | 6 (99.6%); 4 (0.4%) | 6 (99.2%); 4 (0.8%) | 6 (100%) |
FIM | 35±2 | 34±3 | 35±0 |
DN4 | 0.7±1.0 | 0.9±1.2 | 0.5±0.8 |
AFO: ankle-foot orthosis; SIS-FES: semi-implanted selective functional electrical stimulation; MWFC: modified walking functional categories; FIM: functional independence measure; DN4: neuropathic pain diagnostic questionnaire. Results expressed as mean±standard deviation.